Medical Condition News

RSS

Positive results from Alkermes combination Phase 1 study of ALKS 33 and buprenorphine for cocaine addiction

Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.

25 Oct 2010

Enrollment complete in ViroPharma's Phase 2 study evaluating subcutaneous delivery of Cinryze

ViroPharma Incorporated today announced that it has completed enrollment in its Phase 2 study evaluating subcutaneous delivery of Cinryze™ (C1esterase inhibitor [human]). This multi-center, open-label, multi-dose Phase 2 study is designed to evaluate the safety, pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze in adolescent and adult subjects with hereditary angioedema (HAE).

25 Oct 2010

Marathon running without proper training can damage the heart

Is running a marathon good for you or can it damage the heart?

25 Oct 2010

Rethink Autism provides free online video to help child with autism for Halloween-related social interactions

How does a family with a child on the autism spectrum participate in Halloween activities. That question is pondered by more families than ever before. The Centers for Disease Control (CDC) estimates that an average of 1 in 110 children in the United States has an Autism Spectrum Disorder (ASD).

25 Oct 2010

Seattle Genetics, Millennium to feature SGN-35 in three poster presentations at ISHL symposium

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced that brentuximab vedotin (SGN-35) will be featured in three poster presentations at the 8th International Symposium on Hodgkin Lymphoma (ISHL) being held October 23-26, 2010 in Cologne, Germany.

25 Oct 2010

Soligenix reports Phase 2 clinical trial results of orBec for GVHD

Soligenix, Inc. a late-stage biopharmaceutical company, today reported preliminary results from its Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.

25 Oct 2010

Popular Mechanics recognizes three NSF-funded projects with innovation Breakthrough Awards

Popular Mechanics has recognized three NSF-funded projects with innovation Breakthrough Awards: an artificial retina returning sight to those who have lost it; a system that uses "controlled rocking" and energy-dissipating fuses to help buildings withstand earthquakes; and an inexpensive medical microscope built for cell-phones that allows doctors in rural villages to identify malaria-infected blood cells.

25 Oct 2010

New report highlights numerous monoclonal antibodies for treating digestive system cancers

Since the early development of monoclonal antibodies (mAbs), almost forty years ago, twenty-four therapeutic mAbs have been approved, four of them targeting digestive system cancers. Due to this success (two blockbusters reaching sales of over $1 billion), many industrials position themselves on this very attractive sector.

25 Oct 2010

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular Congress 2010 this week.

25 Oct 2010

Antigenics expands HSPPC-96 Phase 2 clinical study in glioma

Antigenics, Inc. today announced the expansion of a phase 2 clinical study of HSPPC-96 (Oncophage® vaccine; vitespen), Antigenics' personalized therapeutic cancer vaccine, in patients with newly diagnosed glioma.

25 Oct 2010

Neptune launches Onemia medical food

Neptune Technologies & Bioressources Inc. enters the pharmaceutical market with the launch of Onemia™, the first medical food of Neptune's subsidiary Acasti Pharma Inc.. Only two years since its foundation, Acasti has completed the development and launch of "Onemia™" on October 21, 2010 at the Cardiometabolic Health Congress meeting in Boston.

25 Oct 2010

Diabetics living in adverse neighborhood conditions more likely to develop lower body functional limitations

A study published earlier this year in the peer reviewed online journal BMC Public Health has found that residing in a neighborhood with adverse living conditions such as low air quality, loud traffic or industrial noise, or poorly maintained streets, sidewalks and yards, makes mobility problems much more likely in late middle-aged African Americans with diabetes.

25 Oct 2010

Researchers publish effects of doctor-designed formula against breast cancer

Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies.

25 Oct 2010

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

HRSA has awarded $1.6 million to support the Sickle Cell Disease Treatment Demonstration Program (SCDTDP). The program is designed to establish practice models for the prevention and treatment of sickle cell disease through the coordinated efforts of providers, key stake holders, affected individuals and their families.

25 Oct 2010

Gene therapy may reverse pulmonary hypertension

A Heart and Stroke Foundation researcher has discovered what could be the first truly effective breakthrough in the diagnosis and treatment of pulmonary hypertension, a devastating, life-threatening condition which results in an enlargement of the heart.

25 Oct 2010

New gene therapy product reduces plasma cholesterol levels

Amsterdam Molecular Therapeutics (AMT) Holding N.V. a leader in the development of gene based therapies, today announced that its gene therapy product incorporating siRNA sequences into microRNA scaffolds to silence Apolipoprotein B100 (AAV-miApoB) was able to significantly lower plasma cholesterol levels in vivo over a period of 18 weeks. These preliminary results suggest that this approach could lead to a treatment for high cholesterol in humans

25 Oct 2010

$Precautions needed against cold-related frostbite, ankle sprains and fractures$

Precautions needed against cold-related frostbite, ankle sprains and fractures

With cold weather on the horizon, podiatrists at Temple University's School of Podiatric Medicine warn that people of all ages need to take precautions to protect their feet from cold-related injuries like frostbite, ankle sprains and fractures.

25 Oct 2010

Experts identify efficient way to increase minority access to colorectal cancer screening

Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis. To help address this problem, a team of healthcare professionals at Memorial Sloan-Kettering Cancer Center has identified an efficient way to increase minority access to lifesaving colorectal cancer screening (CRCS) in communities where multiple barriers to preventive care exist.

25 Oct 2010

Sleep disturbances increase risk of work disability

Sleep disturbances increase the risk of work disability and may slow the return to work process. This is especially true in cases where work disability is due to mental disorders or musculoskeletal diseases. These results come from a recent study conducted by the Finnish Institute of Occupational Health in collaboration with the universities of Turku and London.

25 Oct 2010

Anxiety sensitivity levels may help in choosing medical treatment for AF patients

Levels of anxiety sensitivity may be important in choosing medical treatment for patients with heart failure and atrial fibrillation (AF), Montreal Heart Institute researchers today told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

Medical Condition News

Positive results from Alkermes combination Phase 1 study of ALKS 33 and buprenorphine for cocaine addiction

Enrollment complete in ViroPharma's Phase 2 study evaluating subcutaneous delivery of Cinryze

Marathon running without proper training can damage the heart

Rethink Autism provides free online video to help child with autism for Halloween-related social interactions

Seattle Genetics, Millennium to feature SGN-35 in three poster presentations at ISHL symposium

Soligenix reports Phase 2 clinical trial results of orBec for GVHD

Popular Mechanics recognizes three NSF-funded projects with innovation Breakthrough Awards

New report highlights numerous monoclonal antibodies for treating digestive system cancers

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Antigenics expands HSPPC-96 Phase 2 clinical study in glioma

Neptune launches Onemia medical food

Diabetics living in adverse neighborhood conditions more likely to develop lower body functional limitations

Researchers publish effects of doctor-designed formula against breast cancer

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

Gene therapy may reverse pulmonary hypertension

New gene therapy product reduces plasma cholesterol levels

Precautions needed against cold-related frostbite, ankle sprains and fractures

Experts identify efficient way to increase minority access to colorectal cancer screening

Sleep disturbances increase risk of work disability

Anxiety sensitivity levels may help in choosing medical treatment for AF patients

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Latest News